Adolescent depression care widens past SSRI defaults
Esketamine adolescent indication consideration, ECT and TMS adolescent access, structured measurement-based care, and integrated school-and-medical models are reshaping adolescent depression care.
Adolescent depression has been an SSRI-and-cognitive-behavioural-therapy category with limited specialty depth and chronic capacity gaps in adolescent mental health care. Esketamine adolescent indication consideration is in active discussion based on emerging data, ECT and TMS adolescent access is expanding in selected severe cases, structured measurement-based care models are formalising, and integrated school-and-medical care models are emerging. The adolescent psychiatry workforce capacity is the structural gap that defines commercial reach.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.